Bipartisan lawmakers press Biden administration on MDMA treatment for PTSD

US lawmakers are requesting the Biden administration to approve MDMA-assisted therapy for treating post-traumatic stress disorder (PTSD). Over 60 House members signed a letter, arguing that the FDA’s studies show significant promise in using this therapy. Despite an FDA advisory panel’s concerns about the treatment’s safety, lawmakers believe the FDA should follow the evidence. The FDA’s decision on the application from Lykos Therapeutics is pending and could impact the potential of psychedelic drugs for PTSD treatment.